(Q30379956)

21 June 2017

title

Investment decisions in influenza pandemic contingency planning: cost-effectiveness of stockpiling antiviral drugs. (English)

1 reference

21 June 2017

0 references

1 reference

1 reference

2

Maarten J Postma

1 reference

21 June 2017

Anna K Lugnér

1

1 reference

21 June 2017

publication date

19 August 2009

1 reference

European Journal of Public Health

21 June 2017

published in

1 reference

21 June 2017

volume

19

1 reference

21 June 2017

issue

5

1 reference

21 June 2017

page(s)

516-520

1 reference

The friction cost method for measuring indirect costs of disease.

21 June 2017

cites work

1 reference

12 December 2020

A history of influenza

1 reference

12 December 2020

The treatment of influenza with antiviral drugs

1 reference

12 December 2020

Oseltamivir for treatment of influenza in healthy adults: pooled trial evidence and cost-effectiveness model for Canada

1 reference

12 December 2020

The epidemiology and clinical impact of pandemic influenza.

1 reference

12 December 2020

Pandemic Influenza and Healthcare Demand in the Netherlands: Scenario Analysis

1 reference

12 December 2020

Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.

1 reference

12 December 2020

A study of illness in a group of Cleveland families. XVII. The occurrence of Asian influenza

1 reference

12 December 2020

Containing pandemic influenza at the source.

1 reference

12 December 2020

Strategies for containing an emerging influenza pandemic in Southeast Asia

1 reference

12 December 2020

Cost-benefit of stockpiling drugs for influenza pandemic.

1 reference

12 December 2020

1918 Influenza: the mother of all pandemics

1 reference

12 December 2020

Economics of neuraminidase inhibitor stock piling for pandemic influenza, Singapore

1 reference

12 December 2020

Mitigation strategies for pandemic influenza in the United States.

1 reference

12 December 2020

Strategies for mitigating an influenza pandemic

1 reference

12 December 2020

Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents.

1 reference

12 December 2020

Controlling pandemic flu: the value of international air travel restrictions.

1 reference

12 December 2020

Partially wrong? Partial equilibrium and the economic analysis of public health emergencies of international concern.

1 reference

12 December 2020

Cost-effectiveness of antiviral stockpiling and near-patient testing for potential influenza pandemic.

1 reference

12 December 2020

Optimal allocation of pandemic influenza vaccine depends on age, risk and timing.

1 reference

12 December 2020

Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model.

1 reference

12 December 2020

Dynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic.

1 reference

12 December 2020

Pandemic potential of a strain of influenza A (H1N1): early findings

1 reference

12 December 2020

Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy

1 reference

12 December 2020

A preliminary estimation of the reproduction ratio for new influenza A(H1N1) from the outbreak in Mexico, March-April 2009.

1 reference

12 December 2020

Stockpiling supplies for the next influenza pandemic

1 reference

12 December 2020

Identifiers

DOI

10.1093/EURPUB/CKP119

1 reference

21 June 2017

0 references

1 reference